Please enable JavaScript to continue using this application.

Compare $ORIC vs $TRAX | Chartloom

Compare

$ORIC vs $TRAX

Oric Pharmaceuticals Inc · First Tracks Biotherapeutics Inc

ORIC

Oric Pharmaceuticals Inc

TRAX

First Tracks Biotherapeutics Inc

Compare $ORIC vs $TRAX

Comparing Oric Pharmaceuticals Inc and First Tracks Biotherapeutics Inc

ORICOric Pharmaceuticals Inc

TRAXFirst Tracks Biotherapeutics Inc

ORICOric Pharmaceuticals Inc

Market cap

$1.24B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

46.8%

52W performance

-16.0%

FCF yield

-9.0%

TRAXFirst Tracks Biotherapeutics Inc

Market cap

$1.11B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

67.6%

52W performance

67.6%

FCF yield

0.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ORIC

TRAX

Detailed metrics comparison

ORIC

Oric Pharmaceuticals Inc

TRAX

First Tracks Biotherapeutics Inc

Market Cap

ORIC$1.24B

TRAX$1.11B

Enterprise Value

ORIC$1.20B

TRAX$943M

Price

ORIC$11.99

TRAX$31.85

P/E Ratio

ORICN/A

TRAXN/A

P/S Ratio

ORIC0.00x

TRAX0.00x

EV/Sales

ORIC0.00x

TRAX0.00x

EV/EBITDA

ORIC0.00x

TRAX0.00x

P/B Ratio

ORIC3.32x

TRAX7.04x

P/FCF Ratio

ORICN/A

TRAXN/A

EV/FCF

ORIC-10.72x

TRAX0.00x

PEG Ratio

ORICN/A

TRAXN/A

Forward P/E (NTM)

ORICN/A

TRAXN/A

Forward P/S (NTM)

ORICN/A

TRAXN/A

Revenue (TTM)

ORIC$0

TRAX$0

Revenue Growth (YoY)

ORICN/A

TRAXN/A

Forward Rev Growth

ORIC1520.7%

TRAX0.0%

Gross Margin (TTM)

ORIC0.0%

TRAX0.0%

Operating Margin (TTM)

ORIC0.0%

TRAX0.0%

EBITDA Margin (TTM)

ORIC0.0%

TRAX0.0%

Net Margin (TTM)

ORIC0.0%

TRAX0.0%

FCF Margin (TTM)

ORICN/A

TRAXN/A

Net Income (TTM)

ORIC$-140M

TRAX$-84M

FCF (TTM)

ORIC$-112M

TRAX$0

EPS (TTM)

ORIC-$1.30

TRAX-$2.40

ROE (TTM)

ORIC-3535.0%

TRAX0.0%

ROA (TTM)

ORIC-3339.0%

TRAX0.0%

ROIC (TTM)

ORIC-3535.0%

TRAX0.0%

Cash

ORIC$37M

TRAX$168M

Debt

ORIC$0

TRAX$0

Net Cash/Debt

ORIC$37M

TRAX$168M

Current Ratio (TTM)

ORIC13.19x

TRAX14.28x

Quick Ratio (TTM)

ORIC12.76x

TRAX14.08x

Debt/Equity (TTM)

ORIC0.00x

TRAX0.00x

Debt/Assets (TTM)

ORIC0.0%

TRAX0.0%

Interest Coverage (TTM)

ORICN/A

TRAXN/A

Net Debt/EBITDA (TTM)

ORIC0.00x

TRAX0.00x

Beta

ORIC1.13

TRAX1.60

52W Performance

ORIC-16.0%

TRAX67.6%

YTD Performance

ORIC46.8%

TRAX67.6%

% from 52W High

ORIC-18.3%

TRAX-36.2%

% from 52W Low

ORIC65.8%

TRAX116.4%

Asset Turnover (TTM)

ORIC0.00x

TRAX0.00x

FCF Yield (TTM)

ORIC-9.0%

TRAX0.0%

Earnings Yield (TTM)

ORIC-11.3%

TRAX-7.5%

Dividend Yield (TTM)

ORICN/A

TRAXN/A

Rule of 40

ORIC0.0

TRAX0.0

EV/GP/RG

ORICN/A

TRAXN/A

Ticker research

View ORIC research View TRAX research

Metric	ORIC Oric Pharmaceuticals Inc	TRAX First Tracks Biotherapeutics Inc
Market & Valuation
Market Cap	$1.24B	$1.11B
Enterprise Value	$1.20B	$943M
Price	$11.99	$31.85
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.32x	7.04x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.72x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1520.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-140M	$-84M
FCF (TTM)	$-112M	$0
EPS (TTM)	-$1.30	-$2.40
ROE (TTM)	-3535.0%	0.0%
ROA (TTM)	-3339.0%	0.0%
ROIC (TTM)	-3535.0%	0.0%
Financial Health
Cash	$37M	$168M
Debt	$0	$0
Net Cash/Debt	$37M	$168M
Current Ratio (TTM)	13.19x	14.28x
Quick Ratio (TTM)	12.76x	14.08x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.13	1.60
52W Performance	-16.0%	67.6%
YTD Performance	46.8%	67.6%
% from 52W High	-18.3%	-36.2%
% from 52W Low	65.8%	116.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-9.0%	0.0%
Earnings Yield (TTM)	-11.3%	-7.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ORIC research	View TRAX research

Valuation

P/S Ratio

ORIC

0.00x

TRAX

0.00x

EV/FCF

ORIC

-10.72x

TRAX

0.00x

Growth & revenue

Forward Revenue Growth

ORIC

1520.7%

TRAX

0.0%

Profitability & performance

Gross Margin

ORIC

0.0%

TRAX

0.0%

ROE

TRAX

0.0%

ORIC

-3535.0%

FCF Yield %

TRAX

0.0%

ORIC

-9.0%

52-Week Performance

TRAX

67.6%

ORIC

-16.0%

Detailed metrics comparison

ORIC

Oric Pharmaceuticals Inc

TRAX

First Tracks Biotherapeutics Inc

Market Cap

ORIC$1.24B

TRAX$1.11B

Enterprise Value

ORIC$1.20B

TRAX$943M

Price

ORIC$11.99

TRAX$31.85

P/E Ratio

ORICN/A

TRAXN/A

P/S Ratio

ORIC0.00x

TRAX0.00x

EV/Sales

ORIC0.00x

TRAX0.00x

EV/EBITDA

ORIC0.00x

TRAX0.00x

P/B Ratio

ORIC3.32x

TRAX7.04x

P/FCF Ratio

ORICN/A

TRAXN/A

EV/FCF

ORIC-10.72x

TRAX0.00x

PEG Ratio

ORICN/A

TRAXN/A

Forward P/E (NTM)

ORICN/A

TRAXN/A

Forward P/S (NTM)

ORICN/A

TRAXN/A

Revenue (TTM)

ORIC$0

TRAX$0

Revenue Growth (YoY)

ORICN/A

TRAXN/A

Forward Rev Growth

ORIC1520.7%

TRAX0.0%

Gross Margin (TTM)

ORIC0.0%

TRAX0.0%

Operating Margin (TTM)

ORIC0.0%

TRAX0.0%

EBITDA Margin (TTM)

ORIC0.0%

TRAX0.0%

Net Margin (TTM)

ORIC0.0%

TRAX0.0%

FCF Margin (TTM)

ORICN/A

TRAXN/A

Net Income (TTM)

ORIC$-140M

TRAX$-84M

FCF (TTM)

ORIC$-112M

TRAX$0

EPS (TTM)

ORIC-$1.30

TRAX-$2.40

ROE (TTM)

ORIC-3535.0%

TRAX0.0%

ROA (TTM)

ORIC-3339.0%

TRAX0.0%

ROIC (TTM)

ORIC-3535.0%

TRAX0.0%

Cash

ORIC$37M

TRAX$168M

Debt

ORIC$0

TRAX$0

Net Cash/Debt

ORIC$37M

TRAX$168M

Current Ratio (TTM)

ORIC13.19x

TRAX14.28x

Quick Ratio (TTM)

ORIC12.76x

TRAX14.08x

Debt/Equity (TTM)

ORIC0.00x

TRAX0.00x

Debt/Assets (TTM)

ORIC0.0%

TRAX0.0%

Interest Coverage (TTM)

ORICN/A

TRAXN/A

Net Debt/EBITDA (TTM)

ORIC0.00x

TRAX0.00x

Beta

ORIC1.13

TRAX1.60

52W Performance

ORIC-16.0%

TRAX67.6%

YTD Performance

ORIC46.8%

TRAX67.6%

% from 52W High

ORIC-18.3%

TRAX-36.2%

% from 52W Low

ORIC65.8%

TRAX116.4%

Asset Turnover (TTM)

ORIC0.00x

TRAX0.00x

FCF Yield (TTM)

ORIC-9.0%

TRAX0.0%

Earnings Yield (TTM)

ORIC-11.3%

TRAX-7.5%

Dividend Yield (TTM)

ORICN/A

TRAXN/A

Rule of 40

ORIC0.0

TRAX0.0

EV/GP/RG

ORICN/A

TRAXN/A

Ticker research

View ORIC research View TRAX research

Metric	ORIC Oric Pharmaceuticals Inc	TRAX First Tracks Biotherapeutics Inc
Market & Valuation
Market Cap	$1.24B	$1.11B
Enterprise Value	$1.20B	$943M
Price	$11.99	$31.85
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.32x	7.04x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.72x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	1520.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-140M	$-84M
FCF (TTM)	$-112M	$0
EPS (TTM)	-$1.30	-$2.40
ROE (TTM)	-3535.0%	0.0%
ROA (TTM)	-3339.0%	0.0%
ROIC (TTM)	-3535.0%	0.0%
Financial Health
Cash	$37M	$168M
Debt	$0	$0
Net Cash/Debt	$37M	$168M
Current Ratio (TTM)	13.19x	14.28x
Quick Ratio (TTM)	12.76x	14.08x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.13	1.60
52W Performance	-16.0%	67.6%
YTD Performance	46.8%	67.6%
% from 52W High	-18.3%	-36.2%
% from 52W Low	65.8%	116.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-9.0%	0.0%
Earnings Yield (TTM)	-11.3%	-7.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ORIC research	View TRAX research